Hyaluronic Acid Market Size, Analysis, Share & Forecast 2031
Hyaluronic Acid Market Size, Analysis, Share & Forecast 2031
Segments - Hyaluronic Acid Market by Applications (Vesicoureteral Reflux, Ophthalmic, Osteoarthritis, and Dermal Fillers), End-users (Nutraceutical Industry, Pharmaceutical Industry, and Cosmetic Industry), and Regions (Asia Pacific, North America, Latin America, Europe, and Middle East & Africa) - Global Industry Analysis, Growth, Share, Size, Trends, and Forecast 2023 – 2031
Upcoming
| Report ID :HC-4205
| 4.8 Rating
| 83 Reviews
| 176 Pages
| Format :
Report Description
The hyaluronic acid market size was valued at USD 2.16 Billion in 2022 and is projected to reach USD 4.32 Billion by 2031 , expanding at a CAGR of around 8% during the forecast period, 2023 – 2031. The growth of the market is attributed to increasing ageing population and the development of technologically advanced items.
Hyaluronic acid is a chemical found in the fluids of the eyes and joints. It cushions and lubricates joints and other muscles. Hyaluronic acid is used in cosmetics in several different forms. Hyaluronic acid may also affect how the body responds to injury and help in edema decrease. It is also used during surgeries. It is also infused straight into the body to hydrate and enhance the skin. Hyaluronic acid is injected into the eye by an eye surgeon for cataract surgery. Hyaluronic acid rinse and gel can also be used to treat mouth ulcers.
Market Trends, Drivers, Restraints, and Opportunities
-
Increasing demand less invasive procedures and quick outcomes is projected to fuel the market.
-
Growing aesthetic awareness is estimated to drive the market during the forecast period.
-
Development of cost-effective treatments and products is expected to boost the market during the projected period.
-
Increase in the number of cosmetic clinics and surgeons is projected to fuel the market.
-
Increased demand for hyaluronic acid-based goods such as shampoo, fillers, dermal, and moisturizers, others are driving the hyaluronic acid market.
-
The adoption of vitamin C, sqaulene, ceramides, and other skin care components is projected to hinder the market growth.
-
Strict regulations, particularly for hair and skin products is estimated to impede the market growth.
-
Technological advancements and R&D investments are anticipated to create immense opportunities for the market players.
Scope of the Report
The report on the global hyaluronic acid market includes an assessment of the market, trends, segments, and regional markets. Overview and dynamics have also been included in the report.
|
Attributes |
Details |
|
Report Title |
Hyaluronic Acid Market - Global Industry Analysis, Growth, Share, Size, Trends, and Forecast |
|
Base Year |
2022 |
|
Historic Data |
2016–2021 |
|
Forecast Period |
2023– 2031 |
|
Segmentation |
Applications (Vesicoureteral Reflux, Ophthalmic, Osteoarthritis, and Dermal Fillers) and End-users (Nutraceutical Industry, Pharmaceutical Industry, and Cosmetic Industry) |
|
Regional Scope |
Asia Pacific, North America, Latin America, Europe, and Middle East & Africa |
|
Report Coverage |
Company Share, Market Analysis and Size, Competitive Landscape, Growth Factors, and Trends, and Revenue Forecast |
|
Key Players Covered in the Report |
Maruha Nichiro, Inc.; LG Life Sciences Ltd. (LG Chem.); Bloomage Biotechnology Corp. Ltd.; Shiseido Company, Ltd.; HTL Biotechnology; Lifecore Biomedical, Llc; Ferring B.V.; Smith & Nephew Plc; Zimmer Biomet; Galderma Laboratories L.P.; F. Hoffmann-La Roche Ag; AbbVie; Seikagaku Corporation; Salix Pharmaceuticals; Anika Therapeutics, Inc.; Genzyme Corp.; Sanofi; Allergan; Contipro a.s.; Landec; Kewpie Corporation; Liuzhou Shengqiang Biotech Co.,Ltd.; and Tiansheng Bio |
Market Segment Insights
Osteoarthritis segment accounted for a major market share
Based on applications, the market is segregated into vesicoureteral reflux, ophthalmic, osteoarthritis, and dermal fillers. The osteoarthritis segment is further fragmented into single injection, three-injection, and five-injection. The osteoarthritis segment accounted for a major market share of around 40% in 2021. In the US both hyaluronic acid and corticosteroids injections can be used to treat osteoarthritis, according to the Osteoarthritis Research Society International (OARSI), however viscosupplementation is somewhat more impactful than corticosteroids. Despite the prevalence of painkillers in pain management, viscosupplements are gaining traction as a treatment option. The FDA approved hyaluronan as an osteoarthritis therapy in 1997, and it has since garnered significant market share. Despite having greater treatment costs than its competitors, the single hyaluronic acid injection segment is driving the market. Single-injection therapy is more convenient and decreases hospital visits while also reducing discomfort and side effects. Dermal fillers are the most common and noninvasive injectable procedures, according to the American Society of Plastic Surgeons (ASAPS), and are mainly utilized to treat soft tissue abnormalities of the face. Dermal fillers made of hyaluronic acid are often used to treat rejuvenation, scar correction, eye wrinkles, nasolabial folds, and dark circles. Hyaluronic acid injections are inexpensive, effective, and simple to use, and these benefits are projected to propel the market during the forecast period.
The cosmetic industry segment held around 32% of the total market share in 2021
On the basis of end-users, the market is fragmented into nutraceutical industry, pharmaceutical industry, and cosmetic industry. The cosmetic industry segment held major market share in 2021 and is estimated to maintain its dominance during the forecast period. The growth of the fashion industry boosted the demand for face care goods, which in turn boosted the demand for hyaluronic acid. Rapid urbanization increased the number of salons, which is expected to fuel the segment.
Asia Pacific is projected to register a CAGR of around 6% during the forecast period
In terms of regions, the market is classified as Asia Pacific, North America, Latin America, Europe, and Middle East & Africa. Asia Pacific is projected to register a CAGR of around 6% during the forecast period. The primary factors driving the market include increased knowledge of the applicability of minimally invasive methods, rising disposable income, and the prevalence of large unmet medical requirements in emerging nations such as China, South Korea and India. Furthermore, rapidly ageing populations in Japan and China is estimated to create a substantial market for anti-aging products and services. Furthermore, the population in Asia based countries are affected by western beauty ideals and strive for a volumized look, which is anticipated to drive the market in the region.
Segments
The global hyaluronic acid market has been segmented on the basis of
Applications
- Vesicoureteral Reflux
- Ophthalmic
- Osteoarthritis
- Dermal Fillers
End-users
- Nutraceutical Industry
- Pharmaceutical Industry
- Cosmetic Industry
Regions
- Asia Pacific
- North America
- Latin America
- Europe
- Middle East & Africa
Key Players
- Maruha Nichiro, Inc.
- LG Life Sciences Ltd. (LG Chem.)
- Bloomage Biotechnology Corp. Ltd.
- Shiseido Company, Ltd.
- HTL Biotechnology
- Lifecore Biomedical, Llc
- Ferring B.V.
- Smith & Nephew Plc
- Zimmer Biomet
- Galderma Laboratories L.P.
- F. Hoffmann-La Roche Ag
- AbbVie
- Seikagaku Corporation
- Salix Pharmaceuticals
- Anika Therapeutics, Inc.
- Genzyme Corp.
- Sanofi
- Allergan
- Contipro a.s.
- Landec
- Kewpie Corporation
- Liuzhou Shengqiang Biotech Co.,Ltd.
- Tiansheng Bio
Competitive Landscape
Key players competing in the hyaluronic acid market include Maruha Nichiro, Inc.; LG Life Sciences Ltd. (LG Chem.); Bloomage Biotechnology Corp. Ltd.; Shiseido Company, Ltd.; HTL Biotechnology; Lifecore Biomedical, Llc; Ferring B.V.; Smith & Nephew Plc; Zimmer Biomet; Galderma Laboratories L.P.; F. Hoffmann-La Roche Ag; AbbVie; Seikagaku Corporation; Salix Pharmaceuticals; Anika Therapeutics, Inc.; Genzyme Corp.; Sanofi; Allergan; Contipro a.s.; Landec; Kewpie Corporation; Liuzhou Shengqiang Biotech Co.,Ltd.; and Tiansheng Bio. Some of these players are using several market strategies such as capacity expansion, partnerships, collaborations, mergers, acquisitions, and product launches to enhance their market shares and raise their production line of the business in the coming years. For instance,
- In June 2020, Juvederm Voluma XC, a new hyaluronic acid medicine from AbbVie, has been approved for enhancing the chin line in adults.
- In 2019, JUVÉDERM VOLUMA XC has been approved by the FDA for use with the TSK STERiGLIDE injector for cheek enhancement.
Frequently Asked Questions
Some of the top players in the market include Sanofi; Allergan; Contipro a.s.; Landec; Kewpie Corporation; Liuzhou Shengqiang Biotech Co.,Ltd.; and Tiansheng Bio.
The cosmetic industry segment held around 32% of the total market share in 2022
The hyaluronic acid market is projected to expand at a CAGR of around 8% during the forecast period, 2023 – 2031.
The hyaluronic acid market is projected to reach USD 4.32 billion by 2031.
The hyaluronic acid market size was valued at USD 2.16 billion in 2022.
Table Of Content
1. Executive Summary2. Assumptions and Acronyms Used
3. Research Methodology
4. Hyaluronic Acid Market Overview
4.1. Introduction
4.1.1. Market Taxonomy
4.1.2. Market Definition
4.2. Macro-Economic Factors
4.2.1. Industry Outlook
4.3. Hyaluronic Acid Market Dynamics
4.3.1. Market Drivers
4.3.2. Market Restraints
4.3.3. Opportunity
4.3.4. Market Trends
4.4. Hyaluronic Acid Market - Supply Chain
4.5. Global Hyaluronic Acid Market Forecast
4.5.1. Hyaluronic Acid Market Size (US$ Mn) and Y-o-Y Growth
4.5.2. Hyaluronic Acid Market Size (000’ Units) and Y-o-Y Growth
4.5.3. Hyaluronic Acid Market Absolute $ Opportunity
5. Global Hyaluronic Acid Market Analysis and Forecast by End Users
5.1. Market Trends
5.2. Introduction
5.2.1. Basis Point Share (BPS) Analysis by End Users
5.2.2. Y-o-Y Growth Projections by End Users
5.3. Hyaluronic Acid Market Size and Volume Forecast by End Users
5.3.1. Nutraceutical Industry
5.3.2. Pharmaceutical Industry
5.3.3. Cosmetic Industry
5.4. Absolute $ Opportunity Assessment by End Users
5.5. Market Attractiveness/Growth Potential Analysis by End Users
6. Global Hyaluronic Acid Market Analysis and Forecast by Region
6.1. Market Trends
6.2. Introduction
6.2.1. Basis Point Share (BPS) Analysis by Region
6.2.2. Y-o-Y Growth Projections by Region
6.3. Hyaluronic Acid Market Size and Volume Forecast by Region
6.3.1. North America
6.3.2. Latin America
6.3.3. Europe
6.3.4. Asia Pacific
6.3.5. Middle East and Africa (MEA)
6.4. Absolute $ Opportunity Assessment by Region
6.5. Market Attractiveness/Growth Potential Analysis by Region
6.6. Global Hyaluronic Acid Demand Share Forecast, 2019-2026
7. North America Hyaluronic Acid Market Analysis and Forecast
7.1. Introduction
7.1.1. Basis Point Share (BPS) Analysis by Country
7.1.2. Y-o-Y Growth Projections by Country
7.2. North America Hyaluronic Acid Market Size and Volume Forecast by Country
7.2.1. U.S.
7.2.2. Canada
7.3. Absolute $ Opportunity Assessment by Country
7.4. North America Hyaluronic Acid Market Size and Volume Forecast by End Users
7.4.1. Nutraceutical Industry
7.4.2. Pharmaceutical Industry
7.4.3. Cosmetic Industry
7.5. Basis Point Share (BPS) Analysis by End Users
7.6. Y-o-Y Growth Projections by End Users
7.7. Market Attractiveness/Growth Potential Analysis
7.7.1. By Country
7.7.2. By Product Type
7.7.3. By Application
7.8. North America Hyaluronic Acid Demand Share Forecast, 2019-2026
8. Latin America Hyaluronic Acid Market Analysis and Forecast
8.1. Introduction
8.1.1. Basis Point Share (BPS) Analysis by Country
8.1.2. Y-o-Y Growth Projections by Country
8.1.3. Latin America Average Pricing Analysis
8.2. Latin America Hyaluronic Acid Market Size and Volume Forecast by Country
8.2.1. Brazil
8.2.2. Mexico
8.2.3. Rest of Latin America
8.3. Absolute $ Opportunity Assessment by Country
8.4. Latin America Hyaluronic Acid Market Size and Volume Forecast by End Users
8.4.1. Nutraceutical Industry
8.4.2. Pharmaceutical Industry
8.4.3. Cosmetic Industry
8.5. Basis Point Share (BPS) Analysis by End Users
8.6. Y-o-Y Growth Projections by End Users
8.7. Market Attractiveness/Growth Potential Analysis
8.7.1. By Country
8.7.2. By Product Type
8.7.3. By Application
8.8. Latin America Hyaluronic Acid Demand Share Forecast, 2019-2026
9. Europe Hyaluronic Acid Market Analysis and Forecast
9.1. Introduction
9.1.1. Basis Point Share (BPS) Analysis by Country
9.1.2. Y-o-Y Growth Projections by Country
9.1.3. Europe Average Pricing Analysis
9.2. Europe Hyaluronic Acid Market Size and Volume Forecast by Country
9.2.1. Germany
9.2.2. France
9.2.3. Italy
9.2.4. U.K.
9.2.5. Spain
9.2.6. Russia
9.2.7. Rest of Europe
9.3. Absolute $ Opportunity Assessment by Country
9.4. Europe Hyaluronic Acid Market Size and Volume Forecast by End Users
9.4.1. Nutraceutical Industry
9.4.2. Pharmaceutical Industry
9.4.3. Cosmetic Industry
9.5. Basis Point Share (BPS) Analysis by End Users
9.6. Y-o-Y Growth Projections by End Users
9.7. Market Attractiveness/Growth Potential Analysis
9.7.1. By Country
9.7.2. By Product Type
9.7.3. By Application
9.8. Europe Hyaluronic Acid Demand Share Forecast, 2019-2026
10. Asia Pacific Hyaluronic Acid Market Analysis and Forecast
10.1. Introduction
10.1.1. Basis Point Share (BPS) Analysis by Country
10.1.2. Y-o-Y Growth Projections by Country
10.1.3. Asia Pacific Average Pricing Analysis
10.2. Asia Pacific Hyaluronic Acid Market Size and Volume Forecast by Country
10.2.1. China
10.2.2. Japan
10.2.3. South Korea
10.2.4. India
10.2.5. Australia
10.2.6. Rest of Asia Pacific (APAC)
10.3. Absolute $ Opportunity Assessment by Country
10.4. Asia Pacific Hyaluronic Acid Market Size and Volume Forecast by End Users
10.4.1. Nutraceutical Industry
10.4.2. Pharmaceutical Industry
10.4.3. Cosmetic Industry
10.5. Basis Point Share (BPS) Analysis by End Users
10.6. Y-o-Y Growth Projections by End Users
10.7. Market Attractiveness/Growth Potential Analysis
10.7.1. By Country
10.7.2. By Product Type
10.7.3. By Application
10.8. Asia Pacific Hyaluronic Acid Demand Share Forecast, 2019-2026
11. Middle East & Africa Hyaluronic Acid Market Analysis and Forecast
11.1. Introduction
11.1.1. Basis Point Share (BPS) Analysis by Country
11.1.2. Y-o-Y Growth Projections by Country
11.1.3. Middle East & Africa Average Pricing Analysis
11.2. Middle East & Africa Hyaluronic Acid Market Size and Volume Forecast by Country
11.2.1. Saudi Arabia
11.2.2. South Africa
11.2.3. UAE
11.2.4. Rest of Middle East & Africa (MEA)
11.3. Absolute $ Opportunity Assessment by Country
11.4. Middle East & Africa Hyaluronic Acid Market Size and Volume Forecast by End Users
11.4.1. Nutraceutical Industry
11.4.2. Pharmaceutical Industry
11.4.3. Cosmetic Industry
11.5. Basis Point Share (BPS) Analysis by End Users
11.6. Y-o-Y Growth Projections by End Users
11.7. Market Attractiveness/Growth Potential Analysis
11.7.1. By Country
11.7.2. By Product Type
11.7.3. By Application
11.8. Middle East & Africa Hyaluronic Acid Demand Share Forecast, 2019-2026
12. Competition Landscape
12.1. Global Hyaluronic Acid Market: Market Share Analysis
12.2. Hyaluronic Acid Distributors and Customers
12.3. Hyaluronic Acid Market: Competitive Dashboard
12.4. Company Profiles (Details: Overview, Financials, Developments, Strategy)
12.4.1. Maruha Nichiro, Inc.
12.4.2. LG Life Sciences Ltd. (LG Chem.)
12.4.3. Bloomage Biotechnology Corp. Ltd.
12.4.4. Shiseido Company, Ltd.
12.4.5. HTL Biotechnology
12.4.6. Lifecore Biomedical, Llc
12.4.7. Ferring B.V.
Methodology
Related Reports
Some other reports from this category!
Our Clients
